S Phyllin SR 200: Sustained Release Acebrophyllin 200mg for Asthma

May 31, 2024

S PHYLLIN SR 200

Acebrophyllin (200mg SR)

S PHYLLIN SR 200 combination of Acebrophyllin (200mg SR) is a sustained-release bronchodilator and mucolytic agent used in the treatment of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma. Its extended-release formulation ensures prolonged therapeutic effects, improving patient compliance and outcomes.

Uses :

Chronic Obstructive Pulmonary Disease (COPD): Acebrophyllin (200mg SR) helps in managing symptoms and enhancing lung function in patients with COPD.
Asthma Management: It is also effective in preventing and controlling asthma symptoms, reducing the frequency of asthma attacks and improving overall respiratory health.

Dosage :

Standard Dosage: The recommended dose is one tablet taken once daily, preferably after meals to reduce gastrointestinal discomfort.
Adjustment: Dosage adjustments may be necessary based on individual response and severity of the condition, as advised by a healthcare provider.

Side Effects :

Common Side Effects:
- Nausea
- Headache
- Stomach upset
Serious Side Effects:
- Palpitations
- Tremors
- Allergic reactions

Precautions :

Monitoring: Regular monitoring of liver function and cardiovascular health is recommended during treatment.
Caution: Use with caution in patients with a history of cardiovascular disorders, liver disease, or severe allergies.

Mechanism of Action :

Acebrophyllin works by inhibiting phosphodiesterase and reducing the breakdown of cyclic AMP, leading to the relaxation of bronchial smooth muscles. Additionally, it has mucolytic properties, reducing mucus viscosity and improving airway clearance.

Conclusion :

Acebrophyllin (200mg SR) offers a comprehensive approach to managing COPD and asthma. Its sustained-release formulation ensures prolonged therapeutic effects, improving patient compliance and outcomes. Adhering to prescribed dosages and taking necessary precautions can help maximize benefits and minimize risks.Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.